Maxi Investments CY Ltd acquired a new stake in shares of Bath & Body Works, Inc. (NYSE:BBWI – Free Report) during the third quarter, HoldingsChannel reports. The firm acquired 77,000 shares of the company’s stock, valued at approximately $1,984,000.
A number of other large investors have also modified their holdings of the company. Gabelli Funds LLC boosted its stake in Bath & Body Works by 1.2% during the third quarter. Gabelli Funds LLC now owns 47,536 shares of the company’s stock worth $1,225,000 after buying an additional 542 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. lifted its holdings in shares of Bath & Body Works by 3.7% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 16,700 shares of the company’s stock worth $430,000 after acquiring an additional 600 shares during the period. State of Wyoming boosted its position in shares of Bath & Body Works by 6.2% during the 2nd quarter. State of Wyoming now owns 11,294 shares of the company’s stock valued at $338,000 after acquiring an additional 661 shares in the last quarter. Vident Advisory LLC increased its stake in Bath & Body Works by 2.8% in the second quarter. Vident Advisory LLC now owns 25,229 shares of the company’s stock valued at $756,000 after acquiring an additional 692 shares during the period. Finally, Synovus Financial Corp raised its position in Bath & Body Works by 1.4% in the third quarter. Synovus Financial Corp now owns 56,210 shares of the company’s stock worth $1,448,000 after purchasing an additional 764 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of research firms have weighed in on BBWI. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Bath & Body Works in a report on Wednesday, January 21st. Deutsche Bank Aktiengesellschaft boosted their price target on Bath & Body Works from $21.00 to $22.00 and gave the company a “hold” rating in a research note on Tuesday, March 3rd. UBS Group increased their price objective on Bath & Body Works from $21.00 to $22.00 and gave the stock a “neutral” rating in a research note on Monday, February 23rd. Barclays lifted their price objective on Bath & Body Works from $20.00 to $21.00 and gave the company an “equal weight” rating in a report on Monday, March 2nd. Finally, Zacks Research upgraded shares of Bath & Body Works from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 20th. Three research analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the company’s stock. According to data from MarketBeat, Bath & Body Works currently has a consensus rating of “Hold” and a consensus price target of $24.00.
Bath & Body Works Price Performance
NYSE BBWI opened at $20.44 on Tuesday. The stock’s 50 day simple moving average is $22.37 and its 200 day simple moving average is $22.98. Bath & Body Works, Inc. has a one year low of $14.27 and a one year high of $34.66. The firm has a market cap of $4.18 billion, a PE ratio of 6.49, a price-to-earnings-growth ratio of 1.95 and a beta of 1.48.
Bath & Body Works (NYSE:BBWI – Get Free Report) last posted its quarterly earnings data on Wednesday, March 4th. The company reported $2.05 EPS for the quarter, topping analysts’ consensus estimates of $1.77 by $0.28. The company had revenue of $2.72 billion for the quarter, compared to analyst estimates of $2.59 billion. Bath & Body Works had a negative return on equity of 45.60% and a net margin of 8.90%.The business’s revenue was down 2.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.09 earnings per share. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, equities analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.
Bath & Body Works Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, March 6th. Shareholders of record on Friday, February 20th were issued a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, February 20th. This represents a $0.80 dividend on an annualized basis and a yield of 3.9%. Bath & Body Works’s dividend payout ratio is currently 25.40%.
About Bath & Body Works
Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.
Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.
Further Reading
- Five stocks we like better than Bath & Body Works
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
